PURPOSE: The evaluation of latent tuberculosis infection (LTBI) is recommended before kidney transplantation. The interferon-γ release assay has been reported to be more specific than the tuberculin skin test (TST) for detecting LTBI. We compared the TST and QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening for LTBI and determined the agreement between the two tests in renal transplant recipients before transplantation. METHODS: Adult patients who were evaluated for renal transplantation between May 2010 and February 2012 at Severance Hospital in South Korea were prospectively enrolled. We performed TST and QFT-GIT. RESULTS: Of the 126 patients, 23 (19.3 %) had positive TST results and 53 (42.1 %) had positive QFT-GIT results. Ag...
BACKGROUND: QuantiFeron-TB (QIFN) is a whole-blood interferon-;gamma assay for the recognition of ce...
AbstractInterferon-γ release assay (IGRA) may improve the diagnostic accuracy for latent tuberculosi...
BACKGROUND & AIM: Screening for latent tuberculosis (LTB) is recommended before starting anti-TNF-al...
Introduction: Identification of latent tuberculosis (TB) infection is important in kidney transplant...
It is assumed that about 10% of individuals infected with Mycobacterium tuberculosis develop tubercu...
Summary: Dialysis patients are more likely than the general population to develop active tuberculosi...
IGRA has been approved as an alternative in vitro test to diagnose Mycobacterium TB infection. This ...
Background: Tuberculosis (TB) remains a major worldwide public health problem with over 8.8 million ...
[[abstract]]Background: : Individuals with end-stage renal disease (ESRD) are 10- to 25-fold more li...
Objective: Accurate detection of latent tuberculosis infection (LTBI) is becoming increasingly impor...
Purpose : Surveillance for detecting and managing latent tuberculosis infection (LTBI) is a key comp...
SummaryDialysis patients are more likely than the general population to develop active tuberculosis ...
End stage renal disease (ESRD) is a known risk factor for progression to active tuberculosis (TB) fr...
Interferon-γ release assay (IGRA) may improve the diagnostic accuracy for latent tuberculosis infect...
Background: The relative diagnostic accuracy of interferon γ release assays (IGRAs; based on ELISA [...
BACKGROUND: QuantiFeron-TB (QIFN) is a whole-blood interferon-;gamma assay for the recognition of ce...
AbstractInterferon-γ release assay (IGRA) may improve the diagnostic accuracy for latent tuberculosi...
BACKGROUND & AIM: Screening for latent tuberculosis (LTB) is recommended before starting anti-TNF-al...
Introduction: Identification of latent tuberculosis (TB) infection is important in kidney transplant...
It is assumed that about 10% of individuals infected with Mycobacterium tuberculosis develop tubercu...
Summary: Dialysis patients are more likely than the general population to develop active tuberculosi...
IGRA has been approved as an alternative in vitro test to diagnose Mycobacterium TB infection. This ...
Background: Tuberculosis (TB) remains a major worldwide public health problem with over 8.8 million ...
[[abstract]]Background: : Individuals with end-stage renal disease (ESRD) are 10- to 25-fold more li...
Objective: Accurate detection of latent tuberculosis infection (LTBI) is becoming increasingly impor...
Purpose : Surveillance for detecting and managing latent tuberculosis infection (LTBI) is a key comp...
SummaryDialysis patients are more likely than the general population to develop active tuberculosis ...
End stage renal disease (ESRD) is a known risk factor for progression to active tuberculosis (TB) fr...
Interferon-γ release assay (IGRA) may improve the diagnostic accuracy for latent tuberculosis infect...
Background: The relative diagnostic accuracy of interferon γ release assays (IGRAs; based on ELISA [...
BACKGROUND: QuantiFeron-TB (QIFN) is a whole-blood interferon-;gamma assay for the recognition of ce...
AbstractInterferon-γ release assay (IGRA) may improve the diagnostic accuracy for latent tuberculosi...
BACKGROUND & AIM: Screening for latent tuberculosis (LTB) is recommended before starting anti-TNF-al...